
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Methylfolate (5-MTHF) is the bioactive form of folate that bypasses the MTHFR enzyme conversion step required by folic acid. It directly supports DNA methylation, neurotransmitter synthesis, and homocysteine metabolism at the cellular level.

Reported Benefits (Provisional)
Origin & History
Methylfolate, also known as 5-MTHF or Quatrefolic, is the active form of folic acid. It is produced through chemical synthesis and enzymatic conversion processes.
Research Narrative (Provisional)
Numerous RCTs and meta-analyses confirm methylfolate's role in prenatal health and homocysteine reduction. Emerging studies suggest benefits in mood and cognitive support.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Active form of folic acid. - Water-soluble vitamin. - Involved in methylation processes.
Reported Mechanism (Provisional)
Methylfolate acts as a methyl donor in the one-carbon metabolism cycle, transferring methyl groups to homocysteine via methionine synthase to produce methionine and S-adenosylmethionine (SAMe). This process supports DNA methylation, neurotransmitter synthesis including serotonin and dopamine, and maintains optimal homocysteine levels. Unlike folic acid, 5-MTHF bypasses the methylenetetrahydrofolate reductase (MTHFR) enzyme, making it effective even in individuals with MTHFR genetic polymorphisms.
Clinical Narrative (Provisional)
Clinical trials demonstrate methylfolate's efficacy in reducing neural tube defects by 70% when taken periconceptionally at 400-800 mcg daily. Depression studies show 15mg daily of L-methylfolate as adjunct therapy improved response rates by 18-30% in SSRI-resistant patients across multiple RCTs with 75-242 participants. Cardiovascular studies indicate 5-15mg daily reduces homocysteine levels by 13-25% in 4-12 week trials, though long-term cardiovascular outcome data remains limited.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







